Unknown

Dataset Information

0

Indomethacin-based stimuli-responsive micelles combined with paclitaxel to overcome multidrug resistance.


ABSTRACT: Development of multidrug resistance against antitumor agents is a major limiting factor for the successful chemotherapy. Currently, both amphiphilic polymeric micelles and chemosensitizers have been proposed to overcome MDR during chemotherapy. Herein, the redox-responsive polymeric micelles composed of dextran and indomethacin (as chemosensitizer) using a disulfide bond as the linker are prepared (DEX-SS-IND) for delivery of antitumor agent paclitaxel (PTX). The high level of glutathione in tumor cells selectively breaks the disulfide bond, leading to the rapid breakdown and deformation of redox-responsive polymeric micelles. The data show that DEX-SS-IND can spontaneously form the stable micelles with high loading content (9.48 ± 0.41%), a favorable size of 45 nm with a narrow polydispersity (0.157), good stability, and glutathione-triggered drug release behavior due to the rapid breakdown of disulfide bond between DEX and IND. In vitro antitumor assay shows DEX-SS-IND/PTX micelles effectively inhibit the proliferation of PTX-resistant breast cancer (MCF-7/PTX) cells. More impressively, DEX-SS-IND/PTX micelles possess the improved plasma pharmacokinetics, enhanced antitumor efficacy on tumor growth in the xenograft models of MCF-7/PTX cells, and better in vivo safety. Overall, DEX-SS-IND/PTX micelles display a great potential for cancer treatment, especially for multidrug resistance tumors.

SUBMITTER: Wang S 

PROVIDER: S-EPMC5762321 | biostudies-literature | 2017 Dec

REPOSITORIES: biostudies-literature

altmetric image

Publications

Indomethacin-based stimuli-responsive micelles combined with paclitaxel to overcome multidrug resistance.

Wang Shuanghu S   Tan Xueying X   Li Shujuan S   Zhou Yunfang Y   Geng Peiwu P   Hua Ailian A   Deng Aiping A   Yu Zhihong Z  

Oncotarget 20171130 67


Development of multidrug resistance against antitumor agents is a major limiting factor for the successful chemotherapy. Currently, both amphiphilic polymeric micelles and chemosensitizers have been proposed to overcome MDR during chemotherapy. Herein, the redox-responsive polymeric micelles composed of dextran and indomethacin (as chemosensitizer) using a disulfide bond as the linker are prepared (DEX-SS-IND) for delivery of antitumor agent paclitaxel (PTX). The high level of glutathione in tum  ...[more]

Similar Datasets

| S-EPMC4924499 | biostudies-literature
| S-EPMC5574666 | biostudies-literature
| S-EPMC5501509 | biostudies-literature
| S-EPMC5965378 | biostudies-literature
| S-EPMC5520180 | biostudies-literature
| S-EPMC7470106 | biostudies-literature
| S-EPMC6969923 | biostudies-literature
| S-EPMC5808690 | biostudies-other
| S-EPMC5868599 | biostudies-literature
| S-EPMC8216478 | biostudies-literature